Bayesian Capital Management, LP
Source: SEC Form 13F · as of Mar 2026Bayesian Capital Management, LP holds 13 biotech & pharma companies tracked by BioSniper, totaling $5.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$5.0M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 46,700 | $1.3M |
| NVONovo Nordisk A/S | 28,600 | $1.1M |
| APLSApellis Pharmaceuticals, Inc. | 13,104 | $527K |
| ADMAADMA BIOLOGICS, INC. | 47,700 | $430K |
| JNJJOHNSON & JOHNSON | 1,354 | $331K |
| GILDGILEAD SCIENCES, INC. | 2,167 | $302K |
| ADPTAdaptive Biotechnologies Corp | 19,485 | $270K |
| ABBVAbbVie Inc. | 1,177 | $256K |
| OSCROscar Health Inc. | 14,500 | $166K |
| PGENPRECIGEN, INC. | 39,600 | $153K |
| OCULOCULAR THERAPEUTIX, INC | 11,900 | $101K |
| BBNXBeta Bionics Inc. | 10,017 | $100K |
| MISTMilestone Pharmaceuticals Inc. | 10,015 | $12K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.